CELTRO
CELTRO develops battery-free, energy-harvesting implantable devices for cardiac applications. The technology leverages advanced semiconductor design and nanotechnology to power implants using the body's own energy.
- CEO / Founder
- Gerd Teepe
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $3.2M
- Latest Round
- Grant
- Key Investors
- Free State of Saxony, private investors from Germany and the USA
Technology & Products
Key Products
NanoPower-BioChip technology for energy harvesting, Battery-free pacemakers, Loop recorders, Biosensors
Technological Advantage
Operates efficiently in the nanowatt range using FinFET and FDSOI semiconductor technologies, supported by a strong IP portfolio including multiple European and PCT filings.
Differentiation
Value Proposition
Provides self-powered cardiac implants that eliminate the risks associated with battery replacements, reduce repetitive surgeries, and lower long-term healthcare costs.
How They Differentiate
Innovative battery-free approach reduces surgical risks and maintenance challenges compared to traditional pacemakers.
Market & Competition
Target Customers
Hospitals, cardiologists, and healthcare providers treating patients needing cardiac implants
Industry Verticals
Medical devices, Cardiovascular healthcare, Implantable electronics
Competitors
Medtronic; Traditional battery-powered pacemaker manufacturers; Emerging energy-harvesting device research groups (notably in Asia)
Growth & Milestones
Growth Metrics
Functional silicon ASIC prototype validated May 2026 at 44 nW (pacemaker footprint <100 nW vs µW-class incumbents); third sequential Saxony/EU R&D grant for preclinical studies; peer-reviewed in-vivo energy-harvesting data published; expanding Dresden microelectronics hiring.
Major Milestones
Founded Nov 2019; Seed financing closed Dec 2021, NanoPower-BioChip ASIC prototype confirmed May 2026 (44 nW autonomy; <100 nW with pacing), Peer-reviewed Heart Rhythm Journal paper on in-vivo myocardial energy harvesting (2025), SAB/EU NanoPower BioChip-III grant €1.73M for preclinical autonomous pacemaker (Förderbescheid Feb 2026), Cadence tools partnership for semiconductor IP; Nano Dimension AME collaboration, Multiple EPO/PCT patents including self-sufficient pacemaker
Notable Customers
Collaborative case studies with Nano Dimension